Skip to content
Screener

Bio-Rad Laboratories BIO Prepaid & Other Current

Prepaid & Other Current at other companies

Abbott logo
AbbottABT
$3B+32.7%
Danaher logo
DanaherDHR
$1.81B+1.1%
MaxCyte logo
MaxCyteMXCT
$4.21M+14.3%
Quanterix Corporation logo
Quanterix CorporationQTRX
$8.73M-1.3%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$232.8M-2.9%
Revvity logo
RevvityRVTY
$189.11M+4.1%

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$9.3B+30.0%
Enterprise value$9.78B+19.3%
P/E55.1×+32.7×
P/S3.6×+0.8×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.

The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:19 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000012208-26-000035
ASSETSMarch 31, 2026 / (Unaudited)December 31, 2025
Short-term investments1,057.51,010.9
Accounts receivable, less allowance for credit losses of $4.9 and $5.5 as of March 31, 2026 and December 31, 2025, respectively426.2460.6
Inventory770.5740.7
Prepaid expenses150.0136.5
Other current assets30.727.7
Total current assets2,942.12,906.2
Property, plant and equipment, net527.5539.9
Operating lease right-of-use assets161.9170.0

Item 1. Financial Statements (Unaudited)

FAQ

What is Bio-Rad Laboratories's prepaid & other current?
Bio-Rad Laboratories (BIO) reported prepaid & other current of $150M in Q1 2026.
How has Bio-Rad Laboratories's prepaid & other current changed year-over-year?
Bio-Rad Laboratories's prepaid & other current increased by 19.6% year-over-year, from $125.4M to $150M.
What is the long-term trend for Bio-Rad Laboratories's prepaid & other current?
Over 5 years (2020 to 2025), Bio-Rad Laboratories's prepaid & other current has grown at a 8.5% compound annual growth rate (CAGR), from $90.62M to $136.5M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Bio-Rad Laboratories's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude